These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10567821)

  • 1. Detection of serum anticerebellar antibodies in patients with Miller Fisher syndrome.
    Inoue A; Koh C; Iwahashi T
    Eur Neurol; 1999; 42(4):230-4. PubMed ID: 10567821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
    Shahrizaila N; Yuki N
    Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease.
    Caccavale A; Mignemi L
    J Neuroophthalmol; 2000 Mar; 20(1):61-2. PubMed ID: 10770512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
    van Sorge NM; Yuki N; Koga M; Susuki K; Jansen MD; van Kooten C; Wokke JH; van de Winkel JG; van der Pol WL; van den Berg LH
    J Neuroimmunol; 2007 Jan; 182(1-2):177-84. PubMed ID: 17156858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
    Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
    J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-LM1 antibodies in the sera of patients with Guillain-Barré syndrome, Miller Fisher syndrome, and motor neuron disease.
    Harukawa H; Utsumi H; Asano A; Yoshino H
    J Peripher Nerv Syst; 2002 Mar; 7(1):54-8. PubMed ID: 11939352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive subacute Miller-Fisher syndrome successfully treated with plasmapheresis.
    Ejma M; Waliszewska-Prosół M; Hofman A; Budrewicz S; Podemski R; Bilińska M; Koszewicz M
    Neurol Neurochir Pol; 2015; 49(2):137-8. PubMed ID: 25890931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GQ1b antibody testing in Guillain-Barre syndrome and variants.
    Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
    Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miller Fisher syndrome treated with plasmapheresis during pregnancy: Case report and review of the literature.
    Ángel-Páez JA; Hurtado-Bugna S; Aragón-Mendoza RL; Altman-Restrepo M; Díaz-Yamal IJ; Centanaro-Meza GA
    Rev Colomb Obstet Ginecol; 2021 Jun; 72(2):210-218. PubMed ID: 34506707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analyses of recurrence in Guillain-Barré syndrome and Fisher syndrome].
    Neshige S; Yoshimoto T; Takeshima S; Himeno T; Shimoe Y; Takamatsu K; Kuriyama M
    Rinsho Shinkeigaku; 2014; 54(7):577-80. PubMed ID: 25087560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of disease progression in Miller Fisher and overlap syndromes.
    Verboon C; van Berghem H; van Doorn PA; Ruts L; Jacobs BC
    J Peripher Nerv Syst; 2017 Dec; 22(4):446-450. PubMed ID: 29065229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miller Fisher syndrome and plasmapheresis.
    Kambara C; Matsuo H; Fukudome T; Goto H; Shibuya N
    Ther Apher; 2002 Dec; 6(6):450-3. PubMed ID: 12460409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.
    Buchwald B; Bufler J; Carpo M; Heidenreich F; Pitz R; Dudel J; Nobile-Orazio E; Toyka KV
    Neurology; 2001 Jan; 56(1):67-74. PubMed ID: 11148238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Miller Fisher syndrome with anti GQ1b in Thailand.
    Sawanyawisuth K; Tiamkao S; Jitpimolmard S; Vincent A
    J Med Assoc Thai; 2007 Feb; 90(2):391-3. PubMed ID: 17375649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The detection of anti-cerebellar antibody western blot analysis in serum from a patient with Miller Fisher syndrome].
    Iwahashi T; Inoue A; Koh S; Yanagihara N
    Arerugi; 1995 Sep; 44(9):1176-80. PubMed ID: 8534214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.